“OLIG2 Expression Level Could Be Used As an Independent Prognostic Factor for Patients With Cerebellar Glioblastoma (cGBM)”. Clinics, vol. 78, Mar. 2023, p. 100120, https://doi.org/10.1016/j.clinsp.2022.100120.